Abstract
The oral cavity as the second most various microbial community in the body contains a broad spectrum of microorganisms which are known as the oral microbiome. The oral microbiome includes different types of microbes such as bacteria, fungi, viruses, and protozoa. Numerous factors can affect the equilibrium of the oral microbiome community which can eventually lead to orodental infectious diseases. Periodontitis, dental caries, oral leukoplakia, oral squamous cell carcinoma are some multifactorial infectious diseases in the oral cavity. In defending against infection, the immune system has an essential role. Depending on the speed and specificity of the reaction, immunity is divided into two different types which are named the innate and the adaptive responses but also there is much interaction between them. In these responses, different types of immune cells are present and recent evidence demonstrates that these cell types both within the innate and adaptive immune systems are capable of secreting some extracellular vesicles named exosomes which are involved in the response to infection. Exosomes are 30–150 nm lipid bilayer vesicles that consist of variant molecules, including proteins, lipids, and genetic materials and they have been associated with cell-to-cell communications. However, some kinds of exosomes can be effective on the pathogenicity of various microorganisms and promoting infections, and some other ones have antimicrobial and anti-infective functions in microbial diseases. These discrepancies in performance are due to the origin of the exosome. Exosomes can modulate the innate and specific immune responses of host cells by participating in antigen presentation for activation of immune cells and stimulating the release of inflammatory factors and the expression of immune molecules. Also, mesenchymal stromal/stem cells (MSCs)-derived exosomes participate in immunomodulation by different mechanisms. Ease of expansion and immunotherapeutic capabilities of MSCs, develop their applications in hundreds of clinical trials. Recently, it has been shown that cell-free therapies, like exosome therapies, by having more advantages than previous treatment methods are emerging as a promising strategy for the treatment of several diseases, in particular inflammatory conditions. In orodental infectious disease, exosomes can also play an important role by modulating immunoinflammatory responses. Therefore, MSCs-derived exosomes may have potential therapeutic effects to be a choice for controlling and treatment of orodental infectious diseases.
Introduction
The oral cavity is the second most diverse microbial community in the human body after the gut (Caselli et al., 2020). Numerous microorganisms including fungi, viruses, protozoa, and over 700 species of bacteria in this community are called “microbiome” (Deo and Deshmukh, 2019). The microbiome is a term that was coined by Joshua Lederberg, a Nobel Prize laureate, to explain the ecological community of symbiotic, commensal, and pathogenic microorganisms that share human body space (Kilian et al., 2016). Orodental infections are caused by changes in the balance of microbial populations or the dynamic relationship between them and the oral cavity (Cho and Blaser, 2012; Marsh et al., 2015). In addition, the oral cavity is exposed to external environmental microorganisms that can cause oral diseases (Gerba, 2015).
The host immune system plays an important role in defending against pathogens (Dunkelberger and Song, 2010). At first, It fights against pathogens through innate immunity and then through adaptive immunity (Cerny and Striz, 2019). Although the innate immune system response is general, non-specific, and does not directly target a single pathogen, it provides a defense barrier against all infectious agents (Aderem and Ulevitch, 2000). The skin and mucosal membranes act as a mechanical barrier against pathogens, also epithelial cells contain peptides that have antimicrobial properties (Ganz, 2003; Oppenheim et al., 2003). If the pathogens can get past the primary defense, the second line of defense becomes active (Frank, 2000). In the infected area, an inflammatory response begins due to stimulation of high blood pressure, the blood vessels dilate, and white blood cells leave the veins during diapause to fight the pathogen (Chen et al., 2018). The vessels diameter increase, because of the secretion of “histamine” from mast cells. Mast cells are a type of white blood cell and phagocytes that draw in pathogens and kill them. During the inflammatory response, the infected area becomes red, swollen, and painful (Janeway et al., 2001b; Csaba et al., 2003) and, the immune system may release substances that raise the body temperature and cause fever. An increase in temperature can decelerate the growth of pathogens and the immune system fights against infectious agents more quickly (Evans et al., 2015). Some phagocytic cells detect pathogenic cells and other kill cells in the body and digest them (Bain, 2017). In the human body, some proteins are normally inactive and activated in infection conditions. They create pores in the membrane of pathogenic cells and destroy them. These proteins are unable to distinguish different pathogens from each other and attack all pathogens non-specifically (Janeway et al., 2001a).
Acquired or specific immunity is activated when a pathogen can cross the innate or non-specific immune mechanism (McDade et al., 2016). The cells of the body have signs that the immune system distinguishes them from other foreign cells (Rich and Chaplin, 2019). When the immune system encounters cells that do not have these signs, it recognizes them as aliens and attacks them through specific or acquired mechanisms, using lymphocytes and producing antibodies (Elgert, 2009). This mechanism develops during the growth of the human body. In this way, with the development of the human body and exposure to pathogens and various vaccinations, a library of antibodies from the cells of the immune system related to various pathogens is created in the body. This process is sometimes called “Immunological Memory” because immune cells remember their former enemies (Crotty and Ahmed, 2004). The acquired mechanism produces antibodies to protect the body against foreign agents, for example, if previous pathogens attack the body, it will produce antibodies more quickly and eliminate the infection (Jerne, 1973). Acquired immunity is caused by the presence of antigens. Antigens are usually located on the surface of pathogen cells, and each pathogen has its antigen (Lamm, 1997). The immune system responds to antigens by certain cells or by producing antibodies (Figure 1). Antibodies attack antigens and produce a signal that attracts phagocytes or other killer cells (Davies and Cohen, 1996). In the immune system, cells like mast cells (Raposo et al., 1997), epithelial cells (van Niel et al., 2001; Lin et al., 2005), antigen-presenting cells (Zitvogel et al., 1998), T lymphocytes (Anel et al., 2019), B lymphocytes (Kato et al., 2020), neutrophils (Vargas et al., 2016), and macrophage (Singhto et al., 2018) release small extracellular vesicles (EVs) which called “exosomes.”
FIGURE 1
The Role of Exosomes in Microbial Infections
EVs are made and secreted in normal and diseased states by most types of cells and have an essential role in intercellular communication and facilitate the immunity process They contain a wide range of lipid-bound nanoparticles that vary in size (Yanez-Mo et al., 2015; Maas et al., 2017; Herrmann et al., 2021). There is no certain agreement on markers or specific naming for EV subtypes, and EVs are usually classified according to their biogenesis pathway or their physical properties used for isolation (Théry et al., 2018). In fact, differences in size help to separate different types of EVs. Microvesicles, exosomes, and apoptotic bodies are the three main subtypes of EVs which are distinguished by their biogenesis, size, content, release pathways, and function (Figure 2; Karpman et al., 2017; Doyle and Wang, 2019; Ståhl et al., 2019).
FIGURE 2
In the late 1960s, for the first time, Bonucci (1967) and Anderson (1969) described small, secreted vesicles as small, 100-nm-diameter vesicles secreted by chondrocytes. A special subset of small EVs, between 30 and 150 nm in diameter, are known as exosomes that appear through endosomal biogenesis pathways (Willms et al., 2018; Tschuschke et al., 2020). A wide range of cell types can secrete exosomes, and the size of exosomes can vary even for exosomes secreted from a single cell line (Zhang et al., 2019). Exosomes consist of approximately 4,400 proteins, 194 lipids, 1,639 mRNAs, and 764 miRNAs and as secretory vesicles, the possibility of their physiological function has been defined (Mathivanan et al., 2012; Kim et al., 2013; Zhang et al., 2019; O’Brien et al., 2020). They can regulate the immune system and also interfere with biological processes. Pathogenic infections alter the number of exosomes, their contents, and membrane structure (Li et al., 2006; Zhang et al., 2018).
Infectious diseases like lower respiratory infections, malaria, diarrhea, tuberculosis (TB), human immunodeficiency virus (HIV) infection, and malaria are major reasons for morbidity and mortality worldwide and their treatment is challenging (Murray et al., 2014; Kirtane et al., 2021). Exosomes can interfere with the processes of infectious diseases. On the one hand, they can contribute to the pathogenesis of microorganisms, be effective in the progression of infection, and can fight against pathogens and infections. This functional variation of exosomes depends on the source of cells and their contents. To confirm this, Tables 1, 2 provide examples of the role of exosomes in infectious diseases. Briefly, Table 1 provides examples of the effects of exosomes on the pathogenicity of various microorganisms so that they cause and promote infections, and Table 2 lists several antimicrobial and anti-infective functions of exosomes in microbial diseases.
TABLE 1
| Microorganisms | Pathogens | Exosomes’ effects in promotion of infection | References |
| Bacteria | Staphylococcus aureus | S. aureus-derived exosomes spread the infection in the body by transmission of bacterial pore forming molecule α-toxin to distant cells. | Husmann et al., 2009 |
| Bacillus anthracis | Exosomes from B. anthracis-infected cells transport the lethal toxin virulence factor to sites distal to the infection. | Abrami et al., 2013 | |
| Helicobacter pilori | Exosomes in H. pylori infection are secreted from cytotoxin-associated gene A (CagA)-expressing gastric epithelial cells enter the circulation and deliver CagA, a virulence factor, to distant organs and tissues. | Shimoda et al., 2016 | |
| Viruses | Human T-cell leukemia virus-1 (HTLV-1) | Exosomes produced by HTLV-1-infected T-cell lines deliver the viral transactivator (Tax) protein which can activate transcription in target cells. | Jaworski et al., 2014 |
| HIV-1 | Exosomes derived from HIV-1-infected cells contain proteins of viral and cellular origin that inhibit target cell migration as well as dsRNA/ssRNA which can increase nuclear gene expression and promote infection. | Barclay et al., 2017 | |
| Human herpesvirus 6 (HHV-6) | Exosomes derived from HHV-6-infected cells contain mature virions; therefore, they help spread infection more efficiently | Mori et al., 2008 | |
| Hepatitis A virus (HAV) | Vacuolar protein sorting 4 homolog B (VPS4B) and ALG-2-interacting protein X (ALIX) play an important role in cloaking the HAV released from cells in host-derived membranes so protecting the virion from antibody-mediated neutralization. These enveloped viruses resemble exosomes and can escape the host immune system. | Feng et al., 2013 | |
| Hepatitis B virus (HBV) | Exosomes derived from HBV-infected hepatocytes transport miR-21, miR-29a, and other miRs to Tamm-Horsfall Protein 1 (THP-1) macrophages, which results in suppressing Interleukin 12p35 (IL-12p35) mRNA expression and limitation of host innate immune response. | Kouwaki et al., 2016 | |
| Hepatitis C virus (HCV) | In vitro study has shown that hepatic exosomes by protecting HCV against antibody neutralization can help transmit HCV infection. | Cosset and Dreux, 2014 | |
| Hepatitis E virus (HEV) | HEV RNA-containing particles in an exosome fraction are infectious and cannot be neutralized by anti-HEV antibodies so they protect from the immune response. | Chapuy-Regaud et al., 2017 | |
| Epstein-Barr virus (EBV) | EBV escapes immune responses by sequestering immune effectors like caspase-1, interleukin 1b (IL-1b), interleukin 18 (IL-18), and interleukin 33 (IL-33), in exosomes which are continuously secreted. | Ansari et al., 2013 | |
| HIV type 1 (HIV-1) | Exosomes derived from HIV-1-infected cells allow HIV-1 to replicate inside resting human primary CD4 + T lymphocytes. | Arenaccio et al., 2014 | |
| Yeast | Saccharomyces cerevisiae | Cytosolic Sup35 NM prions are packaged into exosomes which are able to transmit the prion phenotype to neighboring cells. | Liu et al., 2016 |
| Parasites | Trypanosoma brucei | T. brucei rhodesiense EVs mediating non-hereditary virulence factor transfer by containing the serum resistance-associated protein (SRA) and causing host erythrocyte remodeling, inducing anemia. Also, these EVs by transferring the SRA to T. brucei gain the ability to evade innate immunity. | Szempruch et al., 2016 |
| Toxoplasma gondii | Exosomes secreted by T. gondii-infected host cells. L6 cells could change the host cell proliferation and alter the host cell cycle and slight enhancement of S phase in L6 cells. | Kim et al., 2016 | |
| Trypanosoma cruzi | T. cruzi-derived have been shown to increase the secretion of interleukin 4 (IL-4) and interleukin 10 (IL-10) and a diminished inducible nitric oxide synthase expression in CD4 + T cells and macrophages. | Trocoli Torrecilhas et al., 2009 |
The role of exosomes in the development of infections caused by various pathogens.
TABLE 2
| Source of exosomes | Role of exosomes | References |
| Adipose tissue-derived MSCs | Combined with melatonin, an anti-inflammatory hormone, could limit inflammation caused by colitis in vivo. | Chang et al., 2019 |
| Colonic lumen of IBD patients | Contribute to IBD diagnosis by containing significantly higher mRNA and protein levels of IL-6, IL-8, IL-10, and TNF-α compared with those from healthy individuals. | Larabi et al., 2020 |
| Dendritic cells | Stimulate the responses of IL-4 and TNF-α and increase the IL-4 production in CD14 in Malassezia sympodialis infection. | Gehrmann et al., 2011 |
| Dendritic cells | Stimulate the production of IgM, IgG3, and IgG1 types of anti-Cps14 responses in Streptococcus pneumoniae type 14 infection. | Colino and Snapper, 2007 |
| Dendritic cells | Promote intestinal barrier function by activating NF-κB via the exosomal miR-146b in a murine model of colitis. | Nata et al., 2013; Alexander et al., 2015 |
| HBV-infected hepatocytes | Stimulate MyD88, Toll-IL-1 receptor-containing adaptor molecule-1 (TICAM-1), and mitochondrial antiviral signaling (MAVS)-dependent pathways to induce NKG2D ligand expression and evoke NK cells. | Kouwaki et al., 2016 |
| Healthy human semen | Prevent the spread of HIV-1 and reduce the intravaginal proliferation of AIDS in mice as well as the systematic spread of virus and viremia. | Madison et al., 2015 |
| Human vaginal secretions | Have inhibitory properties against HIV-1 infection and protect women against HIV-1 infection as a female innate defense. | Smith and Daniel, 2016 |
| Macrophages | Suppression of IFN-γ stimulated MHC class II and CD64 expression on BMMØ dependent on lipoproteins, TLR2 and MyD88 and also increase secretion of chemokines and stimulate migration of macrophages and splenocyte in Mycobacterium tuberculosis infection. | Singh et al., 2011, 2012 |
| Macrophages | Induce Pro-inflammatory responses dependent on TLR 2, TLR4, and MyD88 in Mycobacterium avium infection. | Bhatnagar et al., 2007 |
| MDSC | Reduce the severity of colitis by inhibiting Th1 proliferation and promoting Treg cell expansion. | Wang et al., 2016 |
| MSCs | Inhibit inflammatory cytokine production by colonic macrophages stimulated with LPS and promote the polarization of these macrophages into M2 phenotype in vitro and also, alleviate colitis by inhibiting expression of IL-7 and iNOS in mouse colonic macrophages in vivo. | Mao et al., 2017; Cao et al., 2019 |
| Mycoplasma-infected tumor cells | Activate the splenic B cells and increase the production of splenocytes cytokines. | Yang et al., 2012 |
| Plasmodium yoelii-infected reticulocytes | Decrease period of parasitemia and increase clearance of parasites, reticulocytosis, immune modulation, elicits IgG2a and IgG2b, and promoted survival time and protect mice from lethal infections. | Martin-Jaular et al., 2011 |
| uMSCs | Contain some small RNAs (let-7f, miR-145, miR-199a, and miR-221) can prevent HCV replication by detecting specific cellular factors or binding directly to the virus genome and intercede the antiviral process. | Qian et al., 2016 |
The function of different sources of exosomes in infectious disease.
IBD, Inflammatory bowel disease; IgM, Immunoglobulin M; IgG3, Immunoglobulin G3; IgG1, Immunoglobulin G1; Cps14, capsular polysaccharide of S. pneumonia type 14; NF-κB, Nuclear factor- κB; MyD88, Myeloid differentiation primary response 88; NKG2D, Natural killer group 2 member D; NK cells, natural killer cells; AIDS, acquired immune deficiency syndrome; IFN-γ, Interferon gamma; BMMØ, bone marrow derived macrophage; TLR 2, toll like receptor 2; TLR 4, toll like receptor 4; MDSC, myeloid-derived suppressor cells; LPS, Lipopolysaccharides; IL-7, interleukin 7; iNOS, inducible nitric oxide synthase; IgG2a, Immunoglobulin G2a; IgG2b, Immunoglobulin G2b; uMSC, umbilical mesenchymal stem cells.
Orodental Infectious Disease
Orodental infectious diseases are caused by both pathogenic microorganisms and the loss of balance in the ecological community of symbiotic microorganisms in the oral cavity. Oral microbial diseases include a wide range of different diseases such as periodontitis and caries. If proper measures are not taken to control and treat mouth-infectious diseases, it can lead to whole-body systemic diseases (Table 3).
TABLE 3
| The human body systems | Disease | References |
| Gastrointestinal system diseases | IBD | Read et al., 2021 |
| Gastrointestinal cancer risk increases | Meurman, 2010 | |
| Pancreatic cancer | Fan et al., 2018 | |
| Nervous system diseases | Alzheimer’s disease | Miklossy, 1993; Riviere et al., 2002; Poole et al., 2013 |
| Endocrine system diseases | Diabetes mellitus | Cianciola et al., 1982; Rylander et al., 1987; Emrich et al., 1991; Thorstensson and Hugoson, 1993; Casarin et al., 2013 |
| Adverse pregnancy outcomes (APOs) | Han et al., 2004, 2010; Madianos et al., 2013 | |
| Obesity | Goodson et al., 2009 | |
| Polycystic ovary syndrome (PCOS) | Lindheim et al., 2016 | |
| Human immune system diseases | Rheumatoid arthritis (RA) | Zhang et al., 2015 |
| HIV infection | Dang et al., 2012; Li et al., 2014a; Heron and Elahi, 2017 | |
| Cardiovascular system diseases | Atherosclerosis | Koren et al., 2011 |
Systemic diseases associated with oral microbiome and orodental infection.
Periodontitis
The periodontium contains the supporting tissues around the structure of the teeth, such as the gingiva, cementum, junctional epithelium, periodontal ligament, and alveolar bone (Taba et al., 2005). Periodontal diseases are a result of periodontal structure destruction (Nanci and Bosshardt, 2006). The prevalence of periodontal disease is very high and more than 90% of adults worldwide suffer from it (Pihlstrom et al., 2005). There are two main categories of periodontal disease: gingivitis and periodontitis (Dorfer et al., 2004). Gingivitis is a milder form of periodontitis and is limited to gum tissue, but periodontitis occurs when the inflammation spreads to deeper tissues and causes loss of supporting connective tissue and alveolar bone (Kononen et al., 2019). The structure and texture of the periodontium can provide a suitable environment for the growth of various microorganisms (Cobb and Killoy, 1990). Microorganisms such as Porphyromonas gingivalis, Tannerella forsythensis, and Treponema denticola play an important role in the development of periodontal disease (Mineoka et al., 2008). T. forsythensis, T. denticola, and Treponema lecithinolyticum can be present in all phases of periodontal disease (Scapoli et al., 2015). Porphyromonas endodontalis and p. gingivalis are more specifically associated with periodontitis and Capnocytophaga ochracea and Campylobacter rectus associated with gingivitis (Scapoli et al., 2015).
Dental Caries
Tooth decay is the most common chronic infectious disease which deals with the chronic and progressive destruction of hard tooth tissue (Ozdemir, 2013; Rathee and Sapra, 2020). In this disease, the hard tooth tissue (enamel and dentin) loses calcium and phosphorus minerals due to acid secretion from cariogenic bacteria (mainly Streptococcus mutans) (Moynihan and Petersen, 2004; Selwitz et al., 2007; Krzysciak et al., 2014). There are various causes for caries, but in general, the four main factors of tooth-adherent specific bacteria, time, susceptible tooth surface, and fermentable carbohydrates play a role in tooth decay (Tahir and Nazir, 2018). These four factors always cause caries, and if each one is not present, the tooth will not decay (Fejerskov, 1997; Sheiham, 2001; Wade, 2013; Kidd and Fejerskov, 2016; Tahir and Nazir, 2018). Tooth decay, in addition to its high prevalence, affects a wide range of age groups, and from children to the elderly, they are at risk for tooth decay (Smith and Szuster, 2000). The most harmful type of caries occurs in childhood and is named “early childhood caries” which has become a common public health problem among preschool children worldwide (Colak et al., 2013; Alazmah, 2017). Numerous factors, including the oral microbiome, affect the incidence of tooth decay in children (Dzidic et al., 2018). Bacteria are considered the main pathogen in tooth decay (Dzidic et al., 2018). Different lactobacilli promote the development of dental caries, but the most important microorganism in the development of dental caries is S. mutans (Loesche, 1996).
Oral Leukoplakia
In 1877, oral leukoplakia was described for the first time by Schwimmer (1877) Oral leukoplakia is one of the most common diseases of the oral mucosa which has malignant potential (van der Waal et al., 1997). According to the Pindborg study, leukoplakia is a white patch on the oral mucosa that cannot be removed and there is no other clinical diagnosis (Mehta et al., 1969; Bánóaczy, 1983). Different microorganisms like Fusobacterium, Leptotrichia, Campylobacter, and Rothia species were detected in oral leukoplakia (Amer et al., 2017).
Oral Squamous Cell Carcinoma
Oral squamous cell carcinoma is the eighth most common cancer worldwide and is the most common oral malignancy (Scully and Bagan, 2009). Numerous hypotheses have been proposed for the association of microorganisms and their products with oral cancer (Perera et al., 2016). Acetaldehyde converted from ethanol, reactive oxygen species, reactive nitrogen species, and volatile sulfur compounds by bacteria are some examples of carcinogenic substances which can cause oral cancer (Meurman and Uittamo, 2008). The metabolization of alcohol to acetaldehyde can be happened by Streptococcus gordonii, Streptococcus mitis, Streptococcus oralis, Streptococcus salivarius, Streptococcus sanguinis, and Candida by the using of alcohol dehydrogenase enzyme (Mantzourani et al., 2009; Marttila et al., 2013). Also, hydrogen sulfide (H2S), methyl mercaptan (CH3SH), and dimethyl sulfide [(CH3)2S] are produced by P. gingivalis, Prevotella intermedia, Aggregatibacter actinomycetemcomitans, and Fusobacterium nucleatum (Nakamura et al., 2018; Suzuki et al., 2019).
Application of Stem Cells-Derived Exosomes in Orodental Infections
Mesenchymal stromal/stem cells (MSCs) are adult pluripotent stem cells with self−renewing potential that have been administered in different types of diseases (Undale et al., 2009; Fitzsimmons et al., 2018). The unique biomedical characteristic of MSCs is their stemness by stimulating their proliferation and differentiating into multi-lineage cells (da Silva Meirelles et al., 2006). MSCs are immunologically safe. Low expression of major histocompatibility complex (MHC) class I molecules and expression of only a few MHC class II molecules make MSCs low immunogenicity cells (Hass et al., 2011; Lee et al., 2014). Immunomodulatory and regenerative functions of MSCs have been shown in various types of diseases (Zappia et al., 2005; Corcione et al., 2006; Wang et al., 2013; Forbes et al., 2014; Le Blanc and Davies, 2015). MSCs-derived exosomes also have angiogenic potential that can improve ischemic diseases (Babaei and Rezaie, 2021). Senescence of MSCs during in vitro expansion makes the cells less productive and can increase disease severity by causing inflammaging (Lee and Yu, 2020). Also, weak engraftment of infused MSCs, and donor-dependent variations are some limitations of application MSCs in clinical trials (Karp and Leng Teo, 2009; Siegel et al., 2013; Li et al., 2016). An alternative method to improve MSC-based therapy is to use exosomes (Zavatti et al., 2020). Being free of immunogenic problems and not being trapped in the lung or liver like infused MSCs, and keeping the therapeutic functions of their cells of origin make MSC exosomes more suitable for clinical application than MSCs (Table 4; U.S. National Library of Medicine clinicaltrials.gov, 2021). The immunomodulatory function of MSCs and MSC-derived exosomes is the most important clinical feature of their application (Kang et al., 2020). Recent studies show that MSCs can inhibit T cells, B cells, natural killer cells, and dendritic cells and result in immune suppression (Bocelli-Tyndall et al., 2007; Li et al., 2012). Regarding MSCs properties, they have been used in clinical trials over several decades (Kabat et al., 2020). The MSCs mainly modulate the activity of the immune system by paracrine agents and exosomes, and the exosomes play an important role in cellular communication (Xu et al., 2016). MSCs-derived exosomes have a role in tissue regeneration, infection treatment, and inflammation control (Afshar et al., 2021; Zhankina et al., 2021).
TABLE 4
| Disease type | Official study title | Condition or disease | Intervention/treatment | Last update | ClinicalTrials.gov Identifier |
| Cancer | Phase I study of mesenchymal stromal cells-derived exosomes with KrasG12D siRNA for metastatic pancreas cancer patients harboring KrasG12D mutation | KRAS NP_004976.2:p.G12D Metastatic pancreatic adenocarcinoma Pancreatic ductal adenocarcinoma Stage IV pancreatic cancer AJCC v8 | Mesenchymal stromal cells-derived exosomes with KRAS G12D siRNA | April 29, 2021 | NCT03608631 |
| Cardiovascular diseases | Safety and efficacy of allogenic mesenchymal stem cells derived exosome on disability of patients with acute ischemic stroke: a randomized, Single-blind, Placebo-controlled, Phase 1, 2 trial | Cerebrovascular disorders | Exosome | January 25, 2021 | NCT03384433 |
| COVID-19 treatment | A Pilot clinical study on aerosol inhalation of the exosomes derived from allogenic adipose mesenchymal stem cells in the treatment of severe patients with novel coronavirus pneumonia | Coronavirus | MSCs-derived exosomes | September 7, 2020 | NCT04276987 |
| A tolerance clinical study On aerosol inhalation of mesenchymal stem cells exosomes in healthy volunteers | Healthy | Biological: 1X level of MSCs-Exo Biological: 2X level of MSCs-Exo Biological: 4X level of MSCs-Exo Biological: 6X level of MSCs-Exo Biological: 8X level of MSCs-Exo | August 4, 2021 | NCT04313647 | |
| A phase I/II randomized, double blinded, placebo trial to evaluate the safety and potential efficacy of intravenous infusion of zofin for the treatment of moderate to SARS related to COVID-19 infection vs. placebo | Corona virus infection COVID-19 SARS Acute respiratory distress syndrome | Biological: Zofin Other: Placebo | February 23, 2021 | NCT04384445 | |
| Bone marrow mesenchymal stem cell derived extracellular vesicles infusion treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A phase II clinical trial | COVID-19 ARDS Pneumonia, Viral | Biological: DB-001 Other: Intravenous normal saline | July 14, 2021 | NCT04493242 | |
| Mesenchymal stem cell exosomes for the treatment of COVID-19 positive patients with acute respiratory distress syndrome and/or novel coronavirus pneumonia | COVID-19 Novel coronavirus pneumonia Acute respiratory distress syndrome | MSC-exosomes delivered intravenously every other day on an escalating dose: (2:4:8) MSC-exosomes delivered intravenously every other day on an escalating dose (8:4:8) MSC-exosomes delivered intravenously every other day (8:8:8) | July 21, 2021 | NCT04798716 | |
| The protocol of evaluation of safety and efficiency of method of exosome inhalation in SARS-CoV-2 associated two-sided pneumonia | COVID-19 SARS-CoV-2 pneumonia COVID-19 | EXO 1 inhalation EXO 2 inhalation Placebo inhalation | November 4, 2020 | NCT04491240 | |
| The extended protocol of evaluation of safety and efficiency of method of exosome inhalation in COVID-19 associated two-sided pneumonia | COVID-19 SARS-CoV-2 pneumonia COVID-19 | EXO 1 inhalation EXO 2 inhalation Placebo inhalation | October 26, 2020 | NCT04602442 | |
| Immune diseases | Phase 1 study of the effect of cell-free cord blood derived microvesicles On β-cell mass in type 1 diabetes mellitus (T1DM) patients | Diabetes mellitus type 1 | MSC exosomes | May 14, 2014 | NCT02138331 |
| Effect of umbilical mesenchymal stem cells derived exosomes on dry eye in patients with chronic graft vs. host diseases | Dry eye | Umbilical mesenchymal stem cells derived exosomes | February 21, 2020 | NCT04213248 | |
| Effect of adipose derived stem cells exosomes as an adjunctive therapy to scaling and root planning in the treatment of periodontitis: A human clinical trial | Periodontitis | Adipose derived stem cells exosomes | February 17, 2020 | NCT04270006 | |
| Exosome of mesenchymal stem cells for multiple organ dysfuntion syndrome after surgical repaire of acute type A aortic dissection: a Pilot Study | Multiple organ failure | MSC exosomes | May 6, 2020 | NCT04356300 | |
| Neurological diseases | Focused ultrasound delivery of exosomes for treatment of refractory depression, Anxiety, and Neurodegenerative dementias | Refractory depression anxiety, Disorders neurodegenerative diseases | Exosomes | March 5, 2021 | NCT04202770 |
| The use of exosomes In craniofacial neuralgia | Neuralgia | Exosomes | March 5, 2021 | NCT04202783 | |
| Open-label, Single-center, Phase I/II clinical trial to evaluate the safety and the efficacy of exosomes derived from allogenic adipose mesenchymal stem cells in patients with mild to moderate dementia Due to Alzheimer’s disease | Alzheimer’s disease | Biological: Low dosage MSCs-Exos administrated for nasal drip Biological: Mild dosage MSCs-Exos administrated for nasal drip Biological: high dosage MSCs-Exos administrated for nasal drip | June 25, 2021 | NCT04388982 | |
| Wound healing | Mesenchymal stem cells derived exosomes promote healing of large and refractory macular holes | Macular holes | Exosomes derived from mesenchymal stem cells (MSC-Exo) | April 6, 2021 | NCT03437759 |
| A safety study of the administration of mesenchymal stem cell extracellular vesicles in the treatment of dystrophic epidermolysis bullosa wounds | Dystrophic epidermolysis bullosa | AGLE 102 | June 24, 2021 | NCT04173650 |
Some applications of MSCs-derived exosomes in recent clinical trials (U.S. National Library of Medicine clinicaltrials.gov, 2021).
Periodontitis is an inflammatory and destructive disease that has a relationship with several factors such as the pathogens, host inflammation, and immune responses, and the imbalance of multiple T helper cells 17 (Th17)/regulatory T cell (Treg) related cytokines (Wang et al., 2014; Silva et al., 2015; Pan et al., 2019). Bacterial infection is a primary factor in the development of periodontitis, but what ultimately causes periodontitis is improper regulation of the host immune system and inflammatory response (Hajishengallis, 2014, 2015). Th17 cells play a destructive role in the immune balance of periodontitis (Zhao et al., 2011). Over-regulation of Th17 and improper regulation of Treg may lead to periodontal disease through immune-mediated tissue destruction (Zhao et al., 2011; Yang et al., 2014; Karthikeyan et al., 2015). Periodontal ligament stem cells (PDLSCs)-derived exosomes have a similar role with exosomes from MSCs and PDLSCs-derived exosomes contain microRNA−155−5p and regulate Th17/Treg balance by targeting sirtuin−1 in chronic periodontitis (Zheng et al., 2019).
Interleukin-1 (IL-1) and tumor necrosis factor alpha (TNF-α) are pro-inflammatory cytokines that are needed for periodontal inflammation and alveolar bone resorption (Delima et al., 2001; Grauballe et al., 2015). Macrophages that are activated by bacteria can release many inflammatory cytokines, causing gingiva destruction and alveolar bone resorption (Spiller and Koh, 2017; Dutzan et al., 2018; Garaicoa-Pazmino et al., 2019). Macrophages can be divided into two groups which are known as pro-inflammatory macrophages and anti-inflammatory macrophages and periodontal destruction occur following the imbalance of pro-inflammatory/anti-inflammatory macrophages (Gonzalez et al., 2015; Wynn and Vannella, 2016; Zhuang et al., 2019). Pro-inflammatory macrophages play an important role in the production of many inflammatory cytokines such as interleukin 1 beta (IL-1β) and TNF-α. Also, they can stimulate T cells and neutrophils, which cause the destruction of alveolar bone, and they can increase the local expression of receptor activator of nuclear factor ligand (RANKL), which causes osteoclast differentiation in the periodontium (Darveau, 2010; Hienz et al., 2015). In contrast, anti-inflammatory macrophages by secreting the anti-inflammatory mediators play a significant role in the elimination of inflammation and tissue regeneration and contribute to efferocytosis of the apoptotic osteoblastic cells so that mediating bone formation (Zhang et al., 2012; Shapouri-Moghaddam et al., 2018).
Dental pulp stem cells (DPSCs) as a population of dental−derived mesenchymal stem cells have easy accessibility and minimal ethical concerns for use (Mahdiyar et al., 2014; Potdar and Jethmalani, 2015; Mehrabani et al., 2017). The DPSCs have beneficial immunomodulatory and anti-inflammatory properties and have a regulating effect on macrophages of the immune system (Lee et al., 2016; Omi et al., 2016; Galipeau and Sensebe, 2018). Since the therapeutic effects of stem cells are mainly related to the release of paracrine agents, stem cell-derived exosomes, as one of the most important paracrine mediators, show therapeutic effects through immunomodulation (Sun et al., 2018; Riazifar et al., 2019). DPSC-derived exosomes containing miR-1246 can facilitate the conversion of pro-inflammatory macrophages to anti-inflammatory macrophages in the periodontium of mice with periodontitis and accelerate the healing of alveolar bone and the periodontal epithelium (Shen et al., 2020).
In connection with the issue of infectious diseases, exosomes, in addition to treatment, can also help in the diagnosis of infectious diseases. For instance, hand, foot, and mouth disease (HFMD) is a common acute viral infection that has spread worldwide (Guerra et al., 2017). Human enterovirus 71 (EV71) and coxsackie virus A16 (CVA16) are the two main causes of HFMD (Yan et al., 2001; Osterback et al., 2009). HFMD has mild and severe forms which are known as mild HFMD and extremely severe HFMD (Jia et al., 2014), EV71 can cause extremely severe HFMD in which severe neurological symptoms occur and significant mortality (Huang et al., 1999). Many children with extremely severe HFMD die before a definitive diagnosis. There are no effective and reliable methods and tools for diagnosing (Li et al., 2014b; Hossain Khan et al., 2018). A study has shown that patients with different HFMD conditions express a specific type of exosomal miRNA profile (Jia et al., 2014). In fact, these exosomes provide a supplemental biomarker for differential infection stage at an early stage. Therefore, by examining the exosomal content, the disease can be diagnosed, and its different forms can be distinguished from each other (Jia et al., 2014). The immunomodulatory properties of exosomes have enhanced their use in the field of cancer biology. For example, dendritic cells-derived exosomes called “Dexosomes” can be used as a cell-free vaccine for cancer immunotherapy (Nikfarjam et al., 2020). Also, homeostasis and metastasis of tumor cells can change by exosomal and autophagy pathways (Salimi et al., 2020). Radiotherapy may affect the mechanism of paracrine intercellular communication within irradiated tumor tissue and surrounding cells (Jabbari et al., 2019).
Future Perspective of Exosome Therapy
Over the last decades, the knowledge about biogenesis, molecular content, and biological function of exosomes have significant progress and a considerable amount of manuscripts have been published in this field. Exosome therapy as a cell-free therapy is emerging as a promising strategy for the treatment of several diseases, in particular inflammatory conditions. The characteristic properties of exosomes, including the transmission of exosomal competent, protecting it from extracellular degradation, and delivering it in a highly selective manner to target cells, have led to their numerous uses in various fields of treatment. The use of exosomes in clinical applications as well as in the treatment of diseases has both advantages and challenges, some of which are listed in Table 5. Despite the existing limitations, the use of exosomes as a new method in various fields of medical science is phenomenal and inspiring that need more data collection.
TABLE 5
| Advantages | Limitations |
| Efficient cellular entry | Controversies in defining exosome dosage |
| Excellent immune-compatibility | Difficulty in identification of isolation and purification strategy in order to produce optimal results |
| Exerting different therapeutic mechanisms simultaneously | Lack of reliable methods for distinguishing them from other EVs |
| Free of ethical issues | Lack of standardized methods for large-scale production |
| Good stability and protection by having bilayer lipid membrane | Needing appropriate, safe, and confident cell sources of exosomes based on their intended therapeutic use |
| High diagnostic sensitivity and specificity by having multiple diagnostic parameters | Needing considerable attention of stability and storage strategies for clinical and commercial success as off-the-shelf diagnostic and therapeutic tools |
| Intrinsic ability to traverse biological barriers | Short half-life and quick clearance |
| Lower toxicity | Uptake capacity of target cells |
| Minimal trauma than other diagnostic methods in diagnosis of disease | |
| Modification ability | |
| Not immunogenic | |
| Potential targeting ability by the surface-specific domain | |
| Safe and non-tumorigenic | |
| Wide availability in various bodily fluids |
Advantages and limitations of exosomes therapy in clinical applications (Tian et al., 2010; Takahashi et al., 2013; Lötvall et al., 2014; Yu et al., 2014; Théry et al., 2018; Xing et al., 2020; Babaei and Rezaie, 2021).
Conclusion
The oral cavity as a part of the digestive system which is in close contact with the external environment of the body and also by having its special microbiome is prone to a wide range of infectious diseases. In infectious diseases, the pathogenic mechanism of the microorganism is significantly affected by a special type of EVs called exosomes. In this way, these exosomes can be effective in the process of disease development and progression, as well as in the face of preventing and limiting the disease. Exosomes also play an important role in microbial infections by regulating the host immune system. In addition, exosomes can be used in the diagnosis of infectious diseases. Due to the importance of treating oral infectious diseases as well as the ease of using non-cellular therapies, mesenchymal stromal/stem cells-derived exosomes can be considered as a suitable and available option for the treatment of orodental infectious diseases that require more and more extensive studies in the future.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Statements
Author contributions
NJ wrote the manuscript with support from AK and RM. MS helped supervise the project. All authors reviewed the manuscript and approved the final version of the manuscript.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AbramiL.BrandiL.MoayeriM.BrownM. J.KrantzB. A.LepplaS. H.et al (2013). Hijacking multivesicular bodies enables long-term and exosome-mediated long-distance action of anthrax toxin.Cell Rep.5986–996. 10.1016/j.celrep.2013.10.019
2
AderemA.UlevitchR. J. (2000). Toll-like receptors in the induction of the innate immune response.Nature406782–787. 10.1038/35021228
3
AfsharA.ZareM.FarrarZ.HashemiA.BaghbanN.KhoradmehrA.et al (2021). Exosomes of mesenchymal stem cells as nano-cargos for anti-SARS-CoV-2 asRNAs.Mod. Med. Lab. J.411–18.
4
AlazmahA. (2017). Early childhood caries: a review.J. Contemp. Dent. Pract.18732–737.
5
AlexanderM.HuR.RuntschM. C.KageleD. A.MosbrugerT. L.TolmachovaT.et al (2015). Exosome-delivered microRNAs modulate the inflammatory response to endotoxin.Nat. Commun.6:7321. 10.1038/ncomms8321
6
AmerA.GalvinS.HealyC. M.MoranG. P. (2017). The microbiome of potentially malignant oral leukoplakia exhibits enrichment for Fusobacterium, Leptotrichia, Campylobacter, and Rothia Species.Front. Microbiol.8:2391. 10.3389/fmicb.2017.02391
7
AndersonH. C. (1969). Vesicles associated with calcification in the matrix of epiphyseal cartilage.J. Cell Biol.4159–72. 10.1083/jcb.41.1.59
8
AnelA.Gallego-LleydaA.de MiguelD.NavalJ.Martinez-LostaoL. (2019). Role of exosomes in the regulation of T-cell mediated immune responses and in autoimmune disease.Cells8:154. 10.3390/cells8020154
9
AnsariM. A.SinghV. V.DuttaS.VeettilM. V.DuttaD.ChikotiL.et al (2013). Constitutive interferon-inducible protein 16-inflammasome activation during Epstein-Barr virus latency I. II, and III in B and epithelial cells.J. Virol.878606–8623. 10.1128/jvi.00805-13
10
ArenaccioC.ChiozziniC.Columba-CabezasS.ManfrediF.AffabrisE.BaurA.et al (2014). Exosomes from human immunodeficiency virus type 1 (HIV-1)-infected cells license quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef- and ADAM17-dependent mechanism.J. Virol.8811529–11539. 10.1128/JVI.01712-14
11
BabaeiM.RezaieJ. (2021). Application of stem cell-derived exosomes in ischemic diseases: opportunity and limitations.J. Transl. Med.19:196. 10.1186/s12967-021-02863-w
12
BainB. J. (2017). Structure and function of red and white blood cells.Medicine45187–193. 10.1016/j.mpmed.2017.01.011
13
BánóaczyJ. (1983). Oral leukoplakia and other white lesions of the oral mucosa related to dermatological disorders.J. Cutaneous Pathol.10238–256. 10.1111/j.1600-0560.1983.tb01490.x
14
BarclayR. A.SchwabA.DeMarinoC.AkpamagboY.LepeneB.KassayeS.et al (2017). Exosomes from uninfected cells activate transcription of latent HIV-1.J. Biol. Chem.29211682–11701.
15
BhatnagarS.ShinagawaK.CastellinoF. J.SchoreyJ. S. (2007). Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo.Blood1103234–3244. 10.1182/blood-2007-03-079152
16
Bocelli-TyndallC.BracciL.SpagnoliG.BracciniA.BouchenakiM.CeredigR.et al (2007). Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous-and allogeneic-stimulated lymphocytes in vitro.Rheumatology46403–408. 10.1093/rheumatology/kel267
17
BonucciE. (1967). Fine structure of early cartilage calcification.J. Ultrastruct. Res.2033–50. 10.1016/s0022-5320(67)80034-0
18
CaoL.XuH.WangG.LiuM.TianD.YuanZ. (2019). Extracellular vesicles derived from bone marrow mesenchymal stem cells attenuate dextran sodium sulfate-induced ulcerative colitis by promoting M2 macrophage polarization.Int. Immunopharmacol.72264–274. 10.1016/j.intimp.2019.04.020
19
CasarinR. C.BarbagalloA.MeulmanT.SantosV. R.SallumE. A.NocitiF. H.et al (2013). Subgingival biodiversity in subjects with uncontrolled type-2 diabetes and chronic periodontitis.J. Periodontal Res.4830–36. 10.1111/j.1600-0765.2012.01498.x
20
CaselliE.FabbriC.D’AccoltiM.SoffrittiI.BassiC.MazzacaneS.et al (2020). Defining the oral microbiome by whole-genome sequencing and resistome analysis: the complexity of the healthy picture.BMC Microbiol.20:120. 10.1186/s12866-020-01801-y
21
CernyJ.StrizI. (2019). Adaptive innate immunity or innate adaptive immunity?Clin. Sci. (Lond.)1331549–1565. 10.1042/CS20180548
22
ChangC.-L.ChenC.-H.ChiangJ. Y.SunC.-K.ChenY.-L.ChenK.-H.et al (2019). Synergistic effect of combined melatonin and adipose-derived mesenchymal stem cell (ADMSC)-derived exosomes on amelioration of dextran sulfate sodium (DSS)-induced acute colitis.Am. J. Transl. Res.11:2706.
23
Chapuy-RegaudS.DuboisM.Plisson-ChastangC.BonnefoisT.LhommeS.Bertrand-MichelJ.et al (2017). Characterization of the lipid envelope of exosome encapsulated HEV particles protected from the immune response.Biochimie14170–79. 10.1016/j.biochi.2017.05.003
24
ChenL.DengH.CuiH.FangJ.ZuoZ.DengJ.et al (2018). Inflammatory responses and inflammation-associated diseases in organs.Oncotarget97204–7218. 10.18632/oncotarget.23208
25
ChoI.BlaserM. J. (2012). The human microbiome: at the interface of health and disease.Nat. Rev. Genet.13260–270. 10.1038/nrg3182
26
CianciolaL. J.ParkB. H.BruckE.MosovichL.GencoR. J. (1982). Prevalence of periodontal disease in insulin-dependent diabetes mellitus (juvenile diabetes).J. Am. Dent. Assoc.104653–660. 10.14219/jada.archive.1982.0240
27
CobbC. M.KilloyW. J. (1990). Microbial colonization in human periodontal disease: an illustrated tutorial on selected ultrastructural and ecologic considerations.Scanning Microsc.4675–690; discussion 690–1.
28
ColakH.DulgergilC. T.DalliM.HamidiM. M. (2013). Early childhood caries update: a review of causes, diagnoses, and treatments.J. Nat. Sci. Biol. Med.429–38. 10.4103/0976-9668.107257
29
ColinoJ.SnapperC. M. (2007). Dendritic cell-derived exosomes express a Streptococcus pneumoniae capsular polysaccharide type 14 cross-reactive antigen that induces protective immunoglobulin responses against pneumococcal infection in mice.Infect. Immun.75220–230. 10.1128/IAI.01217-06
30
CorcioneA.BenvenutoF.FerrettiE.GiuntiD.CappielloV.CazzantiF.et al (2006). Human mesenchymal stem cells modulate B-cell functions.Blood107367–372. 10.1182/blood-2005-07-2657
31
CossetF. L.DreuxM. (2014). HCV transmission by hepatic exosomes establishes a productive infection.J. Hepatol.60674–675. 10.1016/j.jhep.2013.10.015
32
CrottyS.AhmedR.(eds.) (2004). “Immunological memory in humans,” in Seminars in Immunology (Amsterdam: Elsevier).
33
CsabaG.KovacsP.PallingerE. (2003). Gender differences in the histamine and serotonin content of blood, peritoneal and thymic cells: a comparison with mast cells.Cell Biol. Int.27387–389. 10.1016/s1065-6995(03)00017-9
34
da Silva MeirellesL.ChagastellesP. C.NardiN. B. (2006). Mesenchymal stem cells reside in virtually all post-natal organs and tissues.J. Cell Sci.119(Pt. 11)2204–2213. 10.1242/jcs.02932
35
DangA. T.CottonS.Sankaran-WaltersS.LiC. S.LeeC. Y.DandekarS.et al (2012). Evidence of an increased pathogenic footprint in the lingual microbiome of untreated HIV infected patients.BMC Microbiol.12:153. 10.1186/1471-2180-12-153
36
DarveauR. P. (2010). Periodontitis: a polymicrobial disruption of host homeostasis.Nat. Rev. Microbiol.8481–490. 10.1038/nrmicro2337
37
DaviesD. R.CohenG. H. (1996). Interactions of protein antigens with antibodies.Proc. Natl. Acad. Sci. U.S.A.937–12.
38
DelimaA. J.OatesT.AssumaR.SchwartzZ.CochranD.AmarS.et al (2001). Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis.J. Clin. Periodontol.28233–240. 10.1034/j.1600-051x.2001.028003233.x
39
DeoP. N.DeshmukhR. (2019). Oral microbiome: unveiling the fundamentals.J. Oral Maxillofac. Pathol.23122–128. 10.4103/jomfp.JOMFP_304_18
40
DorferC. E.BecherH.ZieglerC. M.KaiserC.LutzR.JorssD.et al (2004). The association of gingivitis and periodontitis with ischemic stroke.J. Clin. Periodontol.31396–401. 10.1111/j.1600-051x.2004.00579.x
41
DoyleL. M.WangM. Z. (2019). Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis.Cells8:727. 10.3390/cells8070727
42
DunkelbergerJ. R.SongW. C. (2010). Complement and its role in innate and adaptive immune responses.Cell Res.2034–50. 10.1038/cr.2009.139
43
DutzanN.KajikawaT.AbuslemeL.Greenwell-WildT.ZuazoC. E.IkeuchiT.et al (2018). A dysbiotic microbiome triggers TH17 cells to mediate oral mucosal immunopathology in mice and humans.Sci. Transl. Med.10:eaat0797. 10.1126/scitranslmed.aat0797
44
DzidicM.ColladoM. C.AbrahamssonT.ArtachoA.StenssonM.JenmalmM. C.et al (2018). Oral microbiome development during childhood: an ecological succession influenced by postnatal factors and associated with tooth decay.ISME J.122292–2306. 10.1038/s41396-018-0204-z
45
ElgertK. D. (2009). Immunology: Understanding the Immune System.Hoboken, NJ: John Wiley & Sons.
46
EmrichL. J.ShlossmanM.GencoR. J. (1991). Periodontal disease in non-insulin-dependent diabetes mellitus.J. Periodontol.62123–131.
47
EvansS. S.RepaskyE. A.FisherD. T. (2015). Fever and the thermal regulation of immunity: the immune system feels the heat.Nat. Rev. Immunol.15335–349. 10.1038/nri3843
48
FanX.AlekseyenkoA. V.WuJ.PetersB. A.JacobsE. J.GapsturS. M.et al (2018). Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study.Gut67120–127. 10.1136/gutjnl-2016-312580
49
FejerskovO. (1997). Concepts of dental caries and their consequences for understanding the disease.Commun. Dent. Oral Epidemiol.255–12. 10.1111/j.1600-0528.1997.tb00894.x
50
FengZ.HensleyL.McKnightK. L.HuF.MaddenV.PingL.et al (2013). A pathogenic picornavirus acquires an envelope by hijacking cellular membranes.Nature496367–371. 10.1038/nature12029
51
FitzsimmonsR. E. B.MazurekM. S.SoosA.SimmonsC. A. (2018). Mesenchymal stromal/stem cells in regenerative medicine and tissue engineering.Stem Cells Int.2018:8031718. 10.1155/2018/8031718
52
ForbesG. M.SturmM. J.LeongR. W.SparrowM. P.SegarajasingamD.CumminsA. G.et al (2014). A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn’s disease refractory to biologic therapy.Clin. Gastroenterol. Hepatol.1264–71. 10.1016/j.cgh.2013.06.021
53
FrankS. A. (2000). Specific and non-specific defense against parasitic attack.J. Theor. Biol.202283–304. 10.1006/jtbi.1999.1054
54
GalipeauJ.SensebeL. (2018). Mesenchymal stromal cells: clinical challenges and therapeutic opportunities.Cell Stem Cell22824–833. 10.1016/j.stem.2018.05.004
55
GanzT. (2003). Defensins: antimicrobial peptides of innate immunity.Nat. Rev. Immunol.3710–720. 10.1038/nri1180
56
Garaicoa-PazminoC.FretwurstT.SquarizeC. H.BerglundhT.GiannobileW. V.LarssonL.et al (2019). Characterization of macrophage polarization in periodontal disease.J. Clin. Periodontol.46830–839. 10.1111/jcpe.13156
57
GehrmannU.QaziK. R.JohanssonC.HultenbyK.KarlssonM.LundebergL.et al (2011). Nanovesicles from Malassezia sympodialis and host exosomes induce cytokine responses–novel mechanisms for host-microbe interactions in atopic eczema.PLoS One6:e21480. 10.1371/journal.pone.0021480
58
GerbaC. P. (2015). “Environmentally transmitted pathogens,” in Environmental Microbiology, edsMaierR. M.PepperI. L.GerbaC. P. (Amsterdam: Elsevier), 509–550.
59
GonzalezO. A.NovakM. J.KirakoduS.StrombergA.NagarajanR.HuangC. B.et al (2015). Differential gene expression profiles reflecting macrophage polarization in aging and periodontitis gingival tissues.Immunol. Invest.44643–664. 10.3109/08820139.2015.1070269
60
GoodsonJ. M.GroppoD.HalemS.CarpinoE. (2009). Is obesity an oral bacterial disease?J. Dent. Res.88519–523. 10.1177/0022034509338353
61
GrauballeM. B.OstergaardJ. A.SchouS.FlyvbjergA.HolmstrupP. (2015). Effects of TNF-alpha blocking on experimental periodontitis and type 2 diabetes in obese diabetic Zucker rats.J. Clin. Periodontol.42807–816. 10.1111/jcpe.12442
62
GuerraA. M.OrilleE.WaseemM. (2017). Hand Foot and Mouth Disease.Treasure Island, FL: StatPearls.
63
HajishengallisG. (2014). Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response.Trends Immunol.353–11. 10.1016/j.it.2013.09.001
64
HajishengallisG. (2015). Periodontitis: from microbial immune subversion to systemic inflammation.Nat. Rev. Immunol.1530–44. 10.1038/nri3785
65
HanY. W.FardiniY.ChenC.IacampoK. G.PerainoV. A.ShamonkiJ. M.et al (2010). Term stillbirth caused by oral Fusobacterium nucleatum.Obstet. Gynecol.115(2 Pt. 2)442–445. 10.1097/AOG.0b013e3181cb9955
66
HanY. W.RedlineR. W.LiM.YinL.HillG. B.McCormickT. S. (2004). Fusobacterium nucleatum induces premature and term stillbirths in pregnant mice: implication of oral bacteria in preterm birth.Infect. Immun.722272–2279. 10.1128/IAI.72.4.2272-2279.2004
67
HassR.KasperC.BöhmS.JacobsR. (2011). Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC.Cell Commun. Signal.9:12. 10.1186/1478-811X-9-12
68
HeronS. E.ElahiS. (2017). HIV infection and compromised mucosal immunity: oral manifestations and systemic inflammation.Front. Immunol.8:241. 10.3389/fimmu.2017.00241
69
HerrmannI. K.WoodM. J. A.FuhrmannG. (2021). Extracellular vesicles as a next-generation drug delivery platform.Nat. Nanotechnol.16748–759. 10.1038/s41565-021-00931-2
70
HienzS. A.PaliwalS.IvanovskiS. (2015). Mechanisms of bone resorption in periodontitis.J. Immunol. Res.2015:615486.
71
Hossain KhanM. A.AnwarK. S.MuraduzzamanA. K. M.Hossain MollahM. A.Akhter-Ul-AlamS. M.Munisul IslamK.et al (2018). Emerging hand foot mouth disease in Bangladeshi children- first report of rapid appraisal on pocket outbreak: clinico-epidemiological perspective implicating public health emergency.F1000Res.7:1156. 10.12688/f1000research.15170.3
72
HuangC. C.LiuC. C.ChangY. C.ChenC. Y.WangS. T.YehT. F. (1999). Neurologic complications in children with enterovirus 71 infection.N. Engl. J. Med.341936–942. 10.1056/nejm199909233411302
73
HusmannM.BeckmannE.BollerK.KloftN.TenzerS.BobkiewiczW.et al (2009). Elimination of a bacterial pore-forming toxin by sequential endocytosis and exocytosis.FEBS Lett.583337–344. 10.1016/j.febslet.2008.12.028
74
JabbariN.NawazM.RezaieJ. (2019). Bystander effects of ionizing radiation: conditioned media from X-ray irradiated MCF-7 cells increases the angiogenic ability of endothelial cells.Cell Commun. Signal.17:165. 10.1186/s12964-019-0474-8
75
JanewayC. A.Jr.TraversP.WalportM.ShlomchikM. J. (2001a). The Complement System and Innate Immunity. Immunobiology: The Immune System in Health and Disease, 5th Edn. New York, NY: Garland Science.
76
JanewayC. A.Jr.TraversP.WalportM.ShlomchikM. J. (2001b). The Front Line of Host Defense. Immunobiology: The Immune System in Health and Disease, 5th Edn. New York, NY: Garland Science.
77
JaworskiE.NarayananA.Van DuyneR.Shabbeer-MeyeringS.IordanskiyS.SaifuddinM.et al (2014). Human T-lymphotropic virus type 1-infected cells secrete exosomes that contain Tax protein.J. Biol. Chem.28922284–22305. 10.1074/jbc.M114.549659
78
JerneN. K. (1973). The immune system.Sci. Am.22952–60.
79
JiaH. L.HeC. H.WangZ. Y.XuY. F.YinG. Q.MaoL. J.et al (2014). MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.BMC Infect. Dis.14:506. 10.1186/1471-2334-14-506
80
KabatM.BobkovI.KumarS.GrumetM. (2020). Trends in mesenchymal stem cell clinical trials 2004-2018: is efficacy optimal in a narrow dose range?Stem Cells Transl. Med.917–27. 10.1002/sctm.19-0202
81
KangJ. Y.OhM. K.JooH.ParkH. S.ChaeD. H.KimJ.et al (2020). Xeno-Free condition enhances therapeutic functions of human Wharton’s Jelly-Derived mesenchymal stem cells against experimental colitis by upregulated indoleamine 2,3-dioxygenase activity.J. Clin. Med.9:2913. 10.3390/jcm9092913
82
KarpJ. M.Leng TeoG. S. (2009). Mesenchymal stem cell homing: the devil is in the details.Cell Stem Cell4206–216. 10.1016/j.stem.2009.02.001
83
KarpmanD.StåhlA-lArvidssonI. (2017). Extracellular vesicles in renal disease.Nat. Rev. Nephrol.13545–562. 10.1038/nrneph.2017.98
84
KarthikeyanB.Talwar, ArunK. V.KalaivaniS. (2015). Evaluation of transcription factor that regulates T helper 17 and regulatory T cells function in periodontal health and disease.J. Pharm. Bioallied Sci.7(Suppl. 2) S672–S676. 10.4103/0975-7406.163602
85
KatoT.FahrmannJ. F.HanashS. M.VykoukalJ. (2020). Extracellular vesicles mediate B cell immune response and are a potential target for cancer therapy.Cells9:1518. 10.3390/cells9061518
86
KiddE. A.FejerskovO. (2016). Essentials of Dental Caries.Oxford: Oxford University Press.
87
KilianM.ChappleI. L.HannigM.MarshP. D.MeuricV.PedersenA. M.et al (2016). The oral microbiome - an update for oral healthcare professionals.Br. Dent. J.221657–666. 10.1038/sj.bdj.2016.865
88
KimD. K.KangB.KimO. Y.ChoiD. S.LeeJ.KimS. R.et al (2013). EVpedia: an integrated database of high-throughput data for systemic analyses of extracellular vesicles.J. Extracell. Vesicles2:20384. 10.3402/jev.v2i0.20384
89
KimM. J.JungB. K.ChoJ.SongH.PyoK. H.LeeJ. M.et al (2016). Exosomes secreted by Toxoplasma gondii-infected L6 cells: their effects on host cell proliferation and cell cycle changes.Korean J. Parasitol.54147–154. 10.3347/kjp.2016.54.2.147
90
KirtaneA. R.VermaM.KarandikarP.FurinJ.LangerR.TraversoG. (2021). Nanotechnology approaches for global infectious diseases.Nat. Nanotechnol.16369–384. 10.1038/s41565-021-00866-8
91
KononenE.GursoyM.GursoyU. K. (2019). Periodontitis: a multifaceted disease of tooth-supporting tissues.J. Clin. Med.8:1135. 10.3390/jcm8081135
92
KorenO.SporA.FelinJ.FakF.StombaughJ.TremaroliV.et al (2011). Human oral, gut, and plaque microbiota in patients with atherosclerosis.Proc. Natl. Acad. Sci. U.S.A.108(Suppl. 1) 4592–4598. 10.1073/pnas.1011383107
93
KouwakiT.FukushimaY.DaitoT.SanadaT.YamamotoN.MifsudE. J.et al (2016). Extracellular vesicles including exosomes regulate innate immune responses to hepatitis B virus infection.Front Immunol.7:335. 10.3389/fimmu.2016.00335
94
KrzysciakW.JurczakA.KoscielniakD.BystrowskaB.SkalniakA. (2014). The virulence of Streptococcus mutans and the ability to form biofilms.Eur. J. Clin. Microbiol. Infect. Dis.33499–515. 10.1007/s10096-013-1993-7
95
LammM. E. (1997). Interaction of antigens and antibodies at mucosal surfaces.Annu. Rev. Microbiol.51311–340. 10.1146/annurev.micro.51.1.311
96
LarabiA.BarnichN.NguyenH. T. T. (2020). Emerging role of exosomes in diagnosis and treatment of infectious and inflammatory bowel diseases.Cells9:1111. 10.3390/cells9051111
97
Le BlancK.DaviesL. C. (2015). Mesenchymal stromal cells and the innate immune response.Immunol. Lett.168140–146. 10.1016/j.imlet.2015.05.004
98
LeeB. C.YuK. R. (2020). Impact of mesenchymal stem cell senescence on inflammaging.BMB Rep.5365–73. 10.5483/BMBRep.2020.53.2.291
99
LeeM.JeongS. Y.HaJ.KimM.JinH. J.KwonS. J.et al (2014). Low immunogenicity of allogeneic human umbilical cord blood-derived mesenchymal stem cells in vitro and in vivo.Biochem. Biophys. Res. Commun.446983–989. 10.1016/j.bbrc.2014.03.051
100
LeeS.ZhangQ. Z.KarabucakB.LeA. D. (2016). DPSCs from inflamed pulp modulate macrophage function via the TNF-alpha/IDO Axis.J. Dent. Res.951274–1281. 10.1177/0022034516657817
101
LiL.ChenX.WangW. E.ZengC. (2016). How to improve the survival of transplanted mesenchymal stem cell in ischemic heart?Stem Cells Int.2016:9682757. 10.1155/2016/9682757
102
LiX.LiuL.MengD.WangD.ZhangJ.ShiD.et al (2012). Enhanced apoptosis and senescence of bone-marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus.Stem Cells Dev.212387–2394. 10.1089/scd.2011.0447
103
LiX. B.ZhangZ. R.SchluesenerH. J.XuS. Q. (2006). Role of exosomes in immune regulation.J. Cell. Mol. Med.10364–375.
104
LiY.SaxenaD.ChenZ.LiuG.AbramsW. R.PhelanJ. A.et al (2014a). HIV infection and microbial diversity in saliva.J. Clin. Microbiol.521400–1411. 10.1128/JCM.02954-13
105
LiY.ZhangJ.ZhangX. (2014b). Modeling and preventive measures of hand, foot and mouth disease (HFMD) in China.Int. J. Environ. Res. Public Health113108–3117. 10.3390/ijerph110303108
106
LinX. P.AlmqvistN.TelemoE. (2005). Human small intestinal epithelial cells constitutively express the key elements for antigen processing and the production of exosomes.Blood Cells Mol. Dis.35122–128. 10.1016/j.bcmd.2005.05.011
107
LindheimL.BashirM.MunzkerJ.TrummerC.ZachhuberV.PieberT. R.et al (2016). The salivary microbiome in polycystic ovary syndrome (PCOS) and its association with disease-related parameters: a pilot study.Front. Microbiol.7:1270. 10.3389/fmicb.2016.01270
108
LiuS.HossingerA.HofmannJ. P.DennerP.VorbergI. M. (2016). Horizontal transmission of cytosolic Sup35 prions by extracellular vesicles.mBio7:e00915-16. 10.1128/mBio.00915-16
109
LoescheW. J. (1996). “Microbiology of dental decay and periodontal disease,” in Medical Microbiology, 4th Edn, ed.BaronS. (Galveston, TX: University of Texas Medical Branch at Galveston).
110
LötvallJ.HillA. F.HochbergF.BuzásE. I.Di VizioD.GardinerC.et al (2014). Minimal Experimental Requirements for Definition of Extracellular Vesicles and Their Functions: A Position Statement From the International Society for Extracellular Vesicles.Abingdon: Taylor & Francis.
111
MaasS. L. N.BreakefieldX. O.WeaverA. M. (2017). Extracellular vesicles: unique intercellular delivery vehicles.Trends Cell Biol.27172–188. 10.1016/j.tcb.2016.11.003
112
MadianosP. N.BobetsisY. A.OffenbacherS. (2013). Adverse pregnancy outcomes (APOs) and periodontal disease: pathogenic mechanisms.J. Clin. Periodontol.40(Suppl. 14) S170–S180.
113
MadisonM. N.JonesP. H.OkeomaC. M. (2015). Exosomes in human semen restrict HIV-1 transmission by vaginal cells and block intravaginal replication of LP-BM5 murine AIDS virus complex.Virology482189–201. 10.1016/j.virol.2015.03.040
114
MahdiyarP.ZareS.RobatiR.DianatpourM.TorabiK.TamadonA.et al (2014). Isolation, culture, and characterization of human dental pulp mesenchymal stem cells.Int. J. Pediatr.2:44.
115
MantzouraniM.FenlonM.BeightonD. (2009). Association between Bifidobacteriaceae and the clinical severity of root caries lesions.Oral Microbiol. Immunol.2432–37. 10.1111/j.1399-302X.2008.00470.x
116
MaoF.WuY.TangX.KangJ.ZhangB.YanY.et al (2017). Exosomes derived from human umbilical cord mesenchymal stem cells relieve inflammatory bowel disease in mice.Biomed Res. Int.2017:5356760. 10.1155/2017/5356760
117
MarshP. D.HeadD. A.DevineD. A. (2015). Ecological approaches to oral biofilms: control without killing.Caries Res.49(Suppl. 1) 46–54. 10.1159/000377732
118
Martin-JaularL.NakayasuE. S.FerrerM.AlmeidaI. C.Del PortilloH. A. (2011). Exosomes from Plasmodium yoelii-infected reticulocytes protect mice from lethal infections.PLoS One6:e26588. 10.1371/journal.pone.0026588
119
MarttilaE.BowyerP.SanglardD.UittamoJ.KaihovaaraP.SalaspuroM.et al (2013). Fermentative 2-carbon metabolism produces carcinogenic levels of acetaldehyde in Candida albicans.Mol. Oral Microbiol.28281–291. 10.1111/omi.12024
120
MathivananS.FahnerC. J.ReidG. E.SimpsonR. J. (2012). ExoCarta 2012: database of exosomal proteins, RNA and lipids.Nucleic Acids Res.40D1241–D1244. 10.1093/nar/gkr828
121
McDadeT. W.GeorgievA. V.KuzawaC. W. (2016). Trade-offs between acquired and innate immune defenses in humans.Evol. Med. Public Health20161–16. 10.1093/emph/eov033
122
MehrabaniD.MahdiyarP.TorabiK.RobatiR.ZareS.DianatpourM.et al (2017). Growth kinetics and characterization of human dental pulp stem cells: comparison between third molar and first premolar teeth.J. Clin. Exp. Dent.9:e172. 10.4317/jced.52824
123
MehtaF. S.PindborgJ.GuptaP.DaftaryD. (1969). Epidemiologic and histologic study of oral cancer and leukoplakia among 50,915 villagers in India.Cancer24832–849. 10.1002/1097-0142(196910)24:4<832::aid-cncr2820240427>3.0.co;2-u
124
MeurmanJ. H. (2010). Oral microbiota and cancer.J. Oral Microbiol.2:5195.
125
MeurmanJ. H.UittamoJ. (2008). Oral micro-organisms in the etiology of cancer.Acta Odontol. Scand.66321–326. 10.1080/00016350802446527
126
MiklossyJ. (1993). Alzheimer’s disease–a spirochetosis?Neuroreport4841–848. 10.1097/00001756-199307000-00002
127
MineokaT.AwanoS.RikimaruT.KurataH.YoshidaA.AnsaiT.et al (2008). Site-specific development of periodontal disease is associated with increased levels of Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia in subgingival plaque.J. Periodontol.79670–676. 10.1902/jop.2008.070398
128
MoriY.KoikeM.MoriishiE.KawabataA.TangH.OyaizuH.et al (2008). Human herpesvirus-6 induces MVB formation, and virus egress occurs by an exosomal release pathway.Traffic91728–1742. 10.1111/j.1600-0854.2008.00796.x
129
MoynihanP.PetersenP. E. (2004). Diet, nutrition and the prevention of dental diseases.Public Health Nutr.7201–226. 10.1079/phn2003589
130
MurrayC. J.OrtbladK. F.GuinovartC.LimS. S.WolockT. M.RobertsD. A.et al (2014). Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Lancet3841005–1070. 10.1016/S0140-6736(14)60844-8
131
NakamuraS.ShioyaK.HiraokaB. Y.SuzukiN.HoshinoT.FujiwaraT.et al (2018). Porphyromonas gingivalis hydrogen sulfide enhances methyl mercaptan-induced pathogenicity in mouse abscess formation.Microbiology (Reading)164529–539. 10.1099/mic.0.000640
132
NanciA.BosshardtD. D. (2006). Structure of periodontal tissues in health and disease.Periodontol 20004011–28. 10.1111/j.1600-0757.2005.00141.x
133
NataT.FujiyaM.UenoN.MoriichiK.KonishiH.TanabeH.et al (2013). MicroRNA-146b improves intestinal injury in mouse colitis by activating nuclear factor-κB and improving epithelial barrier function.J. Gene Med.15249–260. 10.1002/jgm.2717
134
NikfarjamS.RezaieJ.KashanchiF.JafariR. (2020). Dexosomes as a cell-free vaccine for cancer immunotherapy.J. Exp. Clin. Cancer Res.39:258. 10.1186/s13046-020-01781-x
135
O’BrienK.BreyneK.UghettoS.LaurentL. C.BreakefieldX. O. (2020). RNA delivery by extracellular vesicles in mammalian cells and its applications.Nat. Rev. Mol. Cell Biol.21585–606. 10.1038/s41580-020-0251-y
136
OmiM.HataM.NakamuraN.MiyabeM.KobayashiY.KamiyaH.et al (2016). Transplantation of dental pulp stem cells suppressed inflammation in sciatic nerves by promoting macrophage polarization towards anti-inflammation phenotypes and ameliorated diabetic polyneuropathy.J. Diabetes Investig.7485–496. 10.1111/jdi.12452
137
OppenheimJ.BiragynA.KwakL.YangD. (2003). Roles of antimicrobial peptides such as defensins in innate and adaptive immunity.Ann. Rheum. Dis.62(Suppl. 2) ii17–ii21. 10.1136/ard.62.suppl_2.ii17
138
OsterbackR.VuorinenT.LinnaM.SusiP.HyypiaT.WarisM. (2009). Coxsackievirus A6 and hand, foot, and mouth disease, Finland.Emerg. Infect. Dis.151485–1488.
139
OzdemirD. (2013). Dental caries: the most common disease worldwide and preventive strategies.Int. J. Biol.5:55.
140
PanW.WangQ.ChenQ. (2019). The cytokine network involved in the host immune response to periodontitis.Int. J. Oral Sci.11:30. 10.1038/s41368-019-0064-z
141
PereraM.Al-HebshiN. N.SpeicherD. J.PereraI.JohnsonN. W. (2016). Emerging role of bacteria in oral carcinogenesis: a review with special reference to perio-pathogenic bacteria.J. Oral Microbiol.8:32762. 10.3402/jom.v8.32762
142
PihlstromB. L.MichalowiczB. S.JohnsonN. W. (2005). Periodontal diseases.Lancet3661809–1820.
143
PooleS.SinghraoS. K.KesavaluL.CurtisM. A.CreanS. (2013). Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer’s disease brain tissue.J. Alzheimers Dis.36665–677. 10.3233/JAD-121918
144
PotdarP. D.JethmalaniY. D. (2015). Human dental pulp stem cells: applications in future regenerative medicine.World J. Stem Cells7839–851. 10.4252/wjsc.v7.i5.839
145
QianX.XuC.FangS.ZhaoP.WangY.LiuH.et al (2016). Exosomal MicroRNAs derived from umbilical mesenchymal stem cells inhibit hepatitis C virus infection.Stem Cells Transl. Med.51190–1203. 10.5966/sctm.2015-0348
146
RaposoG.TenzaD.MecheriS.PeronetR.BonnerotC.DesaymardC. (1997). Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation.Mol. Biol. Cell82631–2645. 10.1091/mbc.8.12.2631
147
RatheeM.SapraA. (2020). Dental Caries.Treasure Island, FL: StatPearls.
148
ReadE.CurtisM. A.NevesJ. F. (2021). The role of oral bacteria in inflammatory bowel disease.Nat. Rev. Gastroenterol. Hepatol.18731–742. 10.1038/s41575-021-00488-4
149
RiazifarM.MohammadiM. R.PoneE. J.YeriA.LasserC.SegalinyA. I.et al (2019). Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders.ACS Nano136670–6688. 10.1021/acsnano.9b01004
150
RichR. R.ChaplinD. D. (2019). “The human immune response,” in Clinical Immunology, edsRichR. R.FleisherT. A.ShearerW. T.SchroederH. W.FrewA. J.WeyandC. M. (Amsterdam: Elsevier), 3–17.
151
RiviereG. R.RiviereK. H.SmithK. S. (2002). Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer’s disease.Oral Microbiol. Immunol.17113–118. 10.1046/j.0902-0055.2001.00100.x
152
RylanderH.RambergP.BlohmeG.LindheJ. (1987). Prevalence of periodontal disease in young diabetics.J. Clin. Periodontol.1438–43. 10.1111/j.1600-051x.1987.tb01511.x
153
SalimiL.AkbariA.JabbariN.MojaradB.VahhabiA.SzafertS.et al (2020). Synergies in exosomes and autophagy pathways for cellular homeostasis and metastasis of tumor cells.Cell Biosci.10:64. 10.1186/s13578-020-00426-y
154
ScapoliL.GirardiA.PalmieriA.MartinelliM.CuraF.LauritanoD.et al (2015). Quantitative analysis of periodontal pathogens in periodontitis and gingivitis.J. Biol. Regul. Homeost. Agents29(3 Suppl. 1) 101–110.
155
SchwimmerE. (1877). Die idopathisches Schleimhaut-plaques der Mundhohle (leukoplakia buccalis).Arch. Dermatol. Syphilol.9511–570.
156
ScullyC.BaganJ. (2009). Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications.Oral Dis.15388–399. 10.1111/j.1601-0825.2009.01563.x
157
SelwitzR. H.IsmailA. I.PittsN. B. (2007). Dental caries.Lancet36951–59.
158
Shapouri-MoghaddamA.MohammadianS.VaziniH.TaghadosiM.EsmaeiliS. A.MardaniF.et al (2018). Macrophage plasticity, polarization, and function in health and disease.J. Cell. Physiol.2336425–6440. 10.1002/jcp.26429
159
SheihamA. (2001). Dietary effects on dental diseases.Public Health Nutr.4569–591. 10.1079/phn2001142
160
ShenZ.KuangS.ZhangY.YangM.QinW.ShiX.et al (2020). Chitosan hydrogel incorporated with dental pulp stem cell-derived exosomes alleviates periodontitis in mice via a macrophage-dependent mechanism.Bioact. Mater.51113–1126. 10.1016/j.bioactmat.2020.07.002
161
ShimodaA.UedaK.NishiumiS.Murata-KamiyaN.MukaiS. A.SawadaS.et al (2016). Exosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA.Sci. Rep.6:18346. 10.1038/srep18346
162
SiegelG.KlubaT.Hermanutz-KleinU.BiebackK.NorthoffH.SchäferR. (2013). Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells.BMC Med.11:146. 10.1186/1741-7015-11-146
163
SilvaN.AbuslemeL.BravoD.DutzanN.Garcia-SesnichJ.VernalR.et al (2015). Host response mechanisms in periodontal diseases.J. Appl. Oral Sci. Rev. FOB23329–355. 10.1590/1678-775720140259
164
SinghP. P.LeMaireC.TanJ. C.ZengE.SchoreyJ. S. (2011). Exosomes released from M. tuberculosis infected cells can suppress IFN-γ mediated activation of naïve macrophages.PLoS One6:e18564. 10.1371/journal.pone.0018564
165
SinghP. P.SmithV. L.KarakousisP. C.SchoreyJ. S. (2012). Exosomes isolated from mycobacteria-infected mice or cultured macrophages can recruit and activate immune cells in vitro and in vivo.J. Immunol.189777–785. 10.4049/jimmunol.1103638
166
SinghtoN.KanlayaR.NilnumkhumA.ThongboonkerdV. (2018). Roles of macrophage exosomes in immune response to calcium oxalate monohydrate crystals.Front. Immunol.9:316. 10.3389/fimmu.2018.00316
167
SmithD. K.SzusterF. (2000). Aspects of tooth decay in recently arrived refugees.Aust. N. Z. J. Public Health24623–626. 10.1111/j.1467-842x.2000.tb00529.x
168
SmithJ. A.DanielR. (2016). Human vaginal fluid contains exosomes that have an inhibitory effect on an early step of the HIV-1 life cycle.AIDS302611–2616. 10.1097/QAD.0000000000001236
169
SpillerK. L.KohT. J. (2017). Macrophage-based therapeutic strategies in regenerative medicine.Adv. Drug Deliv. Rev.12274–83. 10.1016/j.addr.2017.05.010
170
StåhlA.-L.JohanssonK.MossbergM.KahnR.KarpmanD. (2019). Exosomes and microvesicles in normal physiology, pathophysiology, and renal diseases.Pediatr. Nephrol.3411–30. 10.1007/s00467-017-3816-z
171
SunY.ShiH.YinS.JiC.ZhangX.ZhangB.et al (2018). Human mesenchymal stem cell derived exosomes alleviate type 2 diabetes mellitus by reversing peripheral insulin resistance and relieving beta-cell destruction.ACS Nano127613–7628. 10.1021/acsnano.7b07643
172
SuzukiN.YonedaM.TakeshitaT.HirofujiT.HaniokaT. (2019). Induction and inhibition of oral malodor.Mol. Oral Microbiol.3485–96. 10.1111/omi.12259
173
SzempruchA. J.SykesS. E.KieftR.DennisonL.BeckerA. C.GartrellA.et al (2016). Extracellular vesicles from trypanosoma brucei mediate virulence factor transfer and cause host anemia.Cell164246–257. 10.1016/j.cell.2015.11.051
174
TabaM.Jr.JinQ.SugaiJ. V.GiannobileW. V. (2005). Current concepts in periodontal bioengineering.Orthod. Craniofac. Res.8292–302. 10.1111/j.1601-6343.2005.00352.x
175
TahirL.NazirR. (2018). Dental Caries, Etiology, and Remedy Through Natural Resources. Dental Caries-Diagnosis, Prevention and Management.London: IntechOpen.
176
TakahashiY.NishikawaM.ShinotsukaH.MatsuiY.OharaS.ImaiT.et al (2013). Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection.J. Biotechnol.16577–84. 10.1016/j.jbiotec.2013.03.013
177
ThéryC.WitwerK. W.AikawaE.AlcarazM. J.AndersonJ. D.AndriantsitohainaR.et al (2018). Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.J. Extracell. Vesicles7:1535750. 10.1080/20013078.2018.1535750
178
ThorstenssonH.HugosonA. (1993). Periodontal disease experience in adult long-duration insulin-dependent diabetics.J. Clin. Periodontol.20352–358. 10.1111/j.1600-051x.1993.tb00372.x
179
TianT.WangY.WangH.ZhuZ.XiaoZ. (2010). Visualizing of the cellular uptake and intracellular trafficking of exosomes by live-cell microscopy.J. Cell. Biochem.111488–496. 10.1002/jcb.22733
180
Trocoli TorrecilhasA. C.TonelliR. R.PavanelliW. R.da SilvaJ. S.SchumacherR. I.de SouzaW.et al (2009). Trypanosoma cruzi: parasite shed vesicles increase heart parasitism and generate an intense inflammatory response.Microbes Infect.1129–39. 10.1016/j.micinf.2008.10.003
181
TschuschkeM.KocherovaI.BryjaA.MozdziakP.Angelova VolponiA.JanowiczK.et al (2020). Inclusion biogenesis, methods of isolation and clinical application of human cellular exosomes.J. Clin. Med.9:436. 10.3390/jcm9020436
182
U.S. National Library of Medicine ClinicalTrials.gov (2021). U.S. National Library of Medicine ClinicalTrials.gov Database. Available online at: http://www.clinicaltrials.gov/(accessed September, 2021).
183
UndaleA. H.WestendorfJ. J.YaszemskiM. J.KhoslaS.(eds.) (2009). “Mesenchymal stem cells for bone repair and metabolic bone diseases,” in Mayo Clinic Proceedings (Amsterdam: Elsevier). 10.1016/S0025-6196(11)60506-5
184
van der WaalI.SchepmanK. P.van der MeijE. H.SmeeleL. E. (1997). Oral leukoplakia: a clinicopathological review.Oral Oncol.33291–301. 10.1016/s1368-8375(97)00002-x
185
van NielG.RaposoG.CandalhC.BoussacM.HershbergR.Cerf-BensussanN.et al (2001). Intestinal epithelial cells secrete exosome-like vesicles.Gastroenterology121337–349. 10.1053/gast.2001.26263
186
VargasA.Roux-DalvaiF.DroitA.LavoieJ. P. (2016). Neutrophil-Derived exosomes: a new mechanism contributing to airway smooth muscle remodeling.Am. J. Respir. Cell Mol. Biol.55450–461. 10.1165/rcmb.2016-0033OC
187
WadeW. G. (2013). The oral microbiome in health and disease.Pharmacol. Res.69137–143.
188
WangD.ZhangH.LiangJ.LiX.FengX.WangH.et al (2013). Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience.Cell Transplant.222267–2277. 10.3727/096368911X582769c
189
WangL.WangJ.JinY.GaoH.LinX. (2014). Oral administration of all-trans retinoic acid suppresses experimental periodontitis by modulating the Th17/Treg imbalance.J. Periodontol.85740–750. 10.1902/jop.2013.130132
190
WangY.TianJ.TangX.RuiK.TianX.MaJ.et al (2016). Exosomes released by granulocytic myeloid-derived suppressor cells attenuate DSS-induced colitis in mice.Oncotarget715356–15368. 10.18632/oncotarget.7324
191
WillmsE.CabanasC.MagerI.WoodM. J. A.VaderP. (2018). Extracellular vesicle heterogeneity: subpopulations, isolation techniques, and diverse functions in cancer progression.Front. Immunol.9:738. 10.3389/fimmu.2018.00738
192
WynnT. A.VannellaK. M. (2016). Macrophages in tissue repair, regeneration, and fibrosis.Immunity44450–462. 10.1016/j.immuni.2016.02.015
193
XingX.HanS.LiZ.LiZ. (2020). Emerging role of exosomes in craniofacial and dental applications.Theranostics108648–8664. 10.7150/thno.48291
194
XuR.GreeningD. W.ZhuH. J.TakahashiN.SimpsonR. J. (2016). Extracellular vesicle isolation and characterization: toward clinical application.J. Clin. Invest.1261152–1162. 10.1172/JCI81129
195
YanJ. J.SuI. J.ChenP. F.LiuC. C.YuC. K.WangJ. R. (2001). Complete genome analysis of enterovirus 71 isolated from an outbreak in Taiwan and rapid identification of enterovirus 71 and coxsackievirus A16 by RT-PCR.J. Med. Virol.65331–339. 10.1002/jmv.2038
196
Yanez-MoM.SiljanderP. R.AndreuZ.ZavecA. B.BorrasF. E.BuzasE. I.et al (2015). Biological properties of extracellular vesicles and their physiological functions.J. Extracell. Vesicles427066.
197
YangC.ChalasaniG.NgY. H.RobbinsP. D. (2012). Exosomes released from Mycoplasma infected tumor cells activate inhibitory B cells.PLoS One7:e36138. 10.1371/journal.pone.0036138
198
YangJ.WuJ.LiuY.HuangJ.LuZ.XieL.et al (2014). Porphyromonas gingivalis infection reduces regulatory T cells in infected atherosclerosis patients.PLoS One9:e86599. 10.1371/journal.pone.0086599
199
YuB.ZhangX.LiX. (2014). Exosomes derived from mesenchymal stem cells.Int. J. Mol. Sci.154142–4157.
200
ZappiaE.CasazzaS.PedemonteE.BenvenutoF.BonanniI.GerdoniE.et al (2005). Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.Blood1061755–1761. 10.1182/blood-2005-04-1496
201
ZavattiM.BerettiF.CasciaroF.BertucciE.MaraldiT. (2020). Comparison of the therapeutic effect of amniotic fluid stem cells and their exosomes on monoiodoacetate-induced animal model of osteoarthritis.Biofactors46106–117. 10.1002/biof.1576
202
ZhangM. Z.YaoB.YangS.JiangL.WangS.FanX.et al (2012). CSF-1 signaling mediates recovery from acute kidney injury.J. Clin. Invest.1224519–4532. 10.1172/JCI60363
203
ZhangW.JiangX.BaoJ.WangY.LiuH.TangL. (2018). Exosomes in pathogen infections: a bridge to deliver molecules and link functions.Front. Immunol.9:90. 10.3389/fimmu.2018.00090
204
ZhangX.ZhangD.JiaH.FengQ.WangD.LiangD.et al (2015). The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment.Nat. Med.21895–905. 10.1038/nm.3914
205
ZhangY.LiuY.LiuH.TangW. H. (2019). Exosomes: biogenesis, biologic function and clinical potential.Cell Biosci.9:19. 10.1186/s13578-019-0282-2
206
ZhankinaR.BaghbanN.AskarovM.SaipiyevaD.IbragimovA.KadirovaB.et al (2021). Mesenchymal stromal/stem cells and their exosomes for restoration of spermatogenesis in non-obstructive azoospermia: a systemic review.Stem Cell Res. Ther.121–12. 10.1186/s13287-021-02295-9
207
ZhaoL.ZhouY.XuY.SunY.LiL.ChenW. (2011). Effect of non-surgical periodontal therapy on the levels of Th17/Th1/Th2 cytokines and their transcription factors in Chinese chronic periodontitis patients.J. Clin. Periodontol.38509–516. 10.1111/j.1600-051X.2011.01712.x
208
ZhengY.DongC.YangJ.JinY.ZhengW.ZhouQ.et al (2019). Exosomal microRNA-155-5p from PDLSCs regulated Th17/Treg balance by targeting sirtuin-1 in chronic periodontitis.J. Cell. Physiol.23420662–20674. 10.1002/jcp.28671
209
ZhuangZ.Yoshizawa-SmithS.GlowackiA.MaltosK.PachecoC.ShehabeldinM.et al (2019). Induction of M2 macrophages prevents bone loss in murine periodontitis models.J. Dent. Res.98200–208. 10.1177/0022034518805984
210
ZitvogelL.RegnaultA.LozierA.WolfersJ.FlamentC.TenzaD.et al (1998). Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes.Nat. Med.4594–600. 10.1038/nm0598-594
Summary
Keywords
exosomes, mesenchymal stromal/stem cells, dental infection controls, dentistry, orodental
Citation
Jafari N, Khoradmehr A, Moghiminasr R and Seyed Habashi M (2022) Mesenchymal Stromal/Stem Cells-Derived Exosomes as an Antimicrobial Weapon for Orodental Infections. Front. Microbiol. 12:795682. doi: 10.3389/fmicb.2021.795682
Received
15 October 2021
Accepted
08 December 2021
Published
04 January 2022
Volume
12 - 2021
Edited by
Nader Tanideh, Shiraz University of Medical Sciences, Iran
Reviewed by
Jafar Rezaie, Urmia University of Medical Sciences, Iran; Reza Shirazi, UNSW Sydney, Australia
Updates
Copyright
© 2022 Jafari, Khoradmehr, Moghiminasr and Seyed Habashi.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Mina Seyed Habashi, mina.s.habashi.64@gmail.com
This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.